Albemarle (NYSE: ALB) reported Q4 EPS of $1.17, $0.07 better than the analyst estimate of $1.10. Revenue for the quarter came in at $879 million versus the consensus estimate of $850.93 million.

"Albemarle reported another solid quarter with Q4 2020 adjusted EBITDA exceeding outlook. This performance is due to the hard work and diligence of our operating teams who ran our businesses safely and efficiently throughout this challenging year," said Albemarle CEO Kent Masters. "As we continue to rebound from last year\'s pandemic-related lows, we are accelerating high-return growth in our Lithium and Bromine businesses and maintaining our focus on operational discipline to drive cost and efficiency improvements."

GUIDANCE:

Albemarle sees FY2021 EPS of $3.25-$3.65, versus the consensus of $4.08. Albemarle sees FY2021 revenue of $3.2-3.3 million, versus the consensus of $3.19 million.

For earnings history and earnings-related data on Albemarle (ALB) click here.